What the Evidence Actually Says Predicts Weight Regain After Stopping a GLP-1

Here is the direct, unglamorous answer: the strongest peer-reviewed evidence available does not show that any specific coaching program, app, or brand changes how much weight comes back after you stop a GLP-1. What it does show is that regain follows a predictable, decelerating curve that plateaus with a real share of the loss still intact, and that structure around food and movement has value independent of whether it moves that particular curve.

Why this question has gotten loud

Weight-loss brands have started publishing their own numbers claiming lower regain than what published research shows, timed to a real and growing anxiety: millions of people are now tapering off a GLP-1, and “will I regain it all” is one of the most common questions in that transition. Marketing analyses from individual companies are not the same thing as controlled, peer-reviewed research, and they should be read that way, interesting as a claim, not as evidence. What follows is what the actual published evidence says, separate from any single company’s numbers.

Does all the weight come back?

Not according to the most detailed trajectory data available. A 2026 systematic review and nonlinear meta-regression in eClinicalMedicine, pooling six randomized trials and over 3,200 participants, modeled the shape of regain after GLP-1 cessation and found it follows a predictable, decelerating pattern rather than a straight line back to baseline. At one year post-cessation, participants had regained about 60 percent of the weight they lost on treatment, and the modeled long-term plateau landed at roughly 75 percent of the lost weight regained, meaning about a quarter of the original loss appeared to persist rather than fully reverse (Budini et al., eClinicalMedicine, 2026).

That is the honest shape of it: real regain, most of it in the first year, slowing down rather than continuing forever, and landing somewhere short of square one. Not the clean, no-regain story any brand’s marketing might suggest. Also not the total-failure story regain sometimes gets treated as.

Does regain happen faster after a drug than after a diet program?

Yes, and this is where the evidence gets specific enough to be useful. A 2026 systematic review and meta-analysis in The BMJ, covering 37 studies and more than 9,300 adults, found weight increased by an average of 0.4 kilograms a month after stopping a weight-management medication, faster for the newer drugs specifically, semaglutide and tirzepatide averaged about 0.8 kilograms a month, and that this rate of regain was consistently faster than what has been observed after people stop a behavioral weight-management program alone (West et al., BMJ, 2026).

That finding on its own supports the idea that how the weight came off matters for what happens next. What the same analysis does not support is the next assumption people tend to make.

Does a coaching program change that curve?

Here is the part that will not make for a great marketing headline, and it is the most important finding in this entire body of evidence for anyone evaluating a brand’s regain claims: in that BMJ meta-analysis, the rate of weight regain was not significantly different based on whether people had a support program in place, either during drug treatment or after stopping it, across the pooled studies. In other words, the population-level data available right now does not show that having a coaching layer, on its own, changes how fast the average person regains weight after a GLP-1.

This is worth sitting with rather than explaining away. It does not mean coaching or structure are worthless, and it is not a reason to stop building good habits. It is a reason to be skeptical of any specific program, ours included, claiming it beats the published regain odds without its own controlled trial to back that up. The honest, RD-level answer to “does a coaching app prevent GLP-1 regain” is: nobody has shown that yet, for any program, at the population level. Anyone telling you otherwise is quoting their own marketing, not a peer-reviewed trial.

So what does the evidence actually support doing?

Not nothing. A separate randomized controlled trial is useful here precisely because it measured something different: not whether coaching beats a published regain curve, but what happens when you add real structure on top of a GLP-1 during a maintenance year. In that trial, adults who combined a structured exercise program with liraglutide preserved significantly more of their improvement in body composition, including a body-fat percentage decrease roughly twice as large, than exercise or the medication alone produced individually (Lundgren et al., New England Journal of Medicine, 2021).

That is a different, narrower, and better-supported claim than “this program prevents regain.” It is: what you do with your body while the medication is working, and while you are tapering off it, has its own independent, measurable effect on what your body looks like and how it functions, separate from whatever the scale number eventually does. Protein at every meal, resistance training, and a real plate structure are not being sold here as a regain-prevention hack. They are worth doing because the evidence for their own, standalone effect is solid, on a GLP-1, off one, or never on one at all.

The honest bottom line

Weight regain after stopping a GLP-1 is common, it is faster than after ending a behavioral program alone, and it follows a predictable curve that plateaus with a real share of the original loss intact rather than reversing completely. No controlled evidence currently shows that any specific coaching program changes that population-level curve, and a healthy amount of skepticism toward any brand claiming otherwise is the correct response, from us included. What the evidence does support is unglamorous and still worth doing: structured, protein-forward eating and continued movement that hold their own value regardless of what the scale is doing that month. If you are actively tapering, the specific week-to-week plan for that transition is the more practical companion piece to this one, and any decision about dosing or timing belongs with your prescriber, not a blog post or an app.